(firstQuint)Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0.

 To treat an intermediate size patient population of bilateral lung transplant patients with CLAD-0.

 Treating physicians will follow standard of care for patients and monitor pulmonary function, fractional exhaled nitric oxide and quality of life of the patients.

 Patient safety will be monitored by assessing changes in these parameters, as well as changes in standard of care measurements (e.

g.

, laboratory values and x-ray images).

.

 Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0@highlight

To treat an intermediate size patient population of bilateral lung transplant patients with CLAD-0.

